Dr. Nathaniel Chin Discusses the FDA Approval of Leqembi on WPR

Nathaniel Chin, MD, at his desk with the Wisconsin Public Radio logo on his computer

Nathaniel Chin, MD, joined host Rob Ferrett on the call-in program “Central Time” on The Ideas Network of Wisconsin Public Radio. Chin discussed the recent FDA approval of the drug Leqembi (lecanemab) to help with early Alzheimer's and answered callers’ questions.

“FDA approves drug to help with early Alzheimer's” aired on Wisconsin Public Radio (WPR) and appeared online at wpr.org on January 11, 2023.